Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 587.00
-2.00 (-0.34%)
Oct 26, 2026, 3:30 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.18 billion as of October 26, 2026. It is the 36,607th most valuable company in the world and the 3,403rd biggest in Japan. Its market cap has decreased by 21.84% in one year.
Market Cap
3.18B
Enterprise Value
1.84B
Revenue
1.42B
Global Rank
Country Rank
#3,403 Japan
PE Ratio
16.47
ChartMarket Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.18B, a decrease of -71.19%. That is a compound annual growth rate of -9.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 3.28B | -12.28% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 5.42B |
| Kringle Pharma | 5.12B |
| PRISM BioLab Co.,LTD | 4.88B |
| Kohjin Bio | 3.92B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.82B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |